Reï¬‚ux eliminated in 93.5%
(514/550) after PEM and 92.8%
(482/520) after EVLA; 3-year
follow-up; no neurologic or
cardiac adverse events after
PEM

Retrospective
nonrandomized
comparative
study

AE, Adverse event; DVT, deep vein thrombosis; EVLA, endovenous laser ab